Patents of polymorphic forms in the pharmaceutical field in Brazil, and its impact on public health
DOI:
https://doi.org/10.3395/reciis.v4i2.679Keywords:
medications, polymorphs, crystal formAbstract
The aim of this article is to show how the National Institute of Industrial Property (INPI) is examining the patent applications related to the polymorphic forms in the pharmaceutical field. In order to do so, there was a survey regarding the number of patent applications in this field. Such applications had already been examined by the INPI from January 2008 to March 2009. Results show that most of the patent applications neither meet some of the patentability requirements, nor some of the descriptive sufficiency condition requirements, in accordance with the legal provisions of Law 9279/96 (LPI) and the exam draft guidelines developed by the Institute.Downloads
Published
How to Cite
Issue
Section
License
Author’s rights: The author retains unrestricted rights over his work.
Rights to reuse: Reciis adopts the Creative Commons License, CC BY-NC non-commercial attribution according to the Policy on Open Access to Knowledge by Oswaldo Cruz Foundation. With this license, access, download, copy, print, share, reuse, and distribution of articles is allowed, provided that it is for non-commercial use and with source citation, granting proper authorship credits and reference to Reciis. In such cases, no permission is required from the authors or editors.
Rights of authors’s deposit / self-archiving: The authors are encouraged to deposit the published version, along with the link of their article in Reciis, in institutional repositories.